[1] Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation[J]. Nat Rev Cancer, 2010, 10(8):550-560. [2] Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes[J]. Nat Rev Cancer, 2004, 4(3):177-183. [3] Banister CE, Liu C, Pirisi L, et al. Identification and characterization of HPV-independent cervical cancers[J]. Oncotarget, 2017, 8(8):13375-13386 [4] Frumovitz M, Burzawa JK, Byers LA, et al. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer[J]. Gynecol Oncol, 2016, 141(3):588-591. [5] Lia X. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlaor cervical cancer[J]. BMC Cancer, 2017, 17(1):252. [6] Chung TK, Van Hummelen P, Chan PK, et al. Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women[J]. Int J Cancer, 2015, 137(4):776-783. [7] Cho SY, Choi M, Ban HJ, et al. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing[J]. Oncotarget, 2017, 8(5):8095-8104. [8] Das P, Bansal A, Rao SN, et al. Somatic variations in cervical cancers in indian patients[J]. PLoS One, 2016, 11(11):e0165878. [9] Zeng Z, Zhou Z, Zhan N, et al. USP10 expression in normal adrenal gland and various adrenal tumors[J]. Endocr Pathol, 2015, 26(4):302-308. [10] Zhao M, Jia W, Jiang WG, et al. ADAM29 expression in human breast cancer and its effects on breast cancer cells in vitro[J]. Anticancer Res, 2016, 36(3):1251-1258.
2017, Vol. 34 
